| Literature DB >> 25122922 |
Youcai Deng1, Jianhong Chu2, Yulin Ren3, Zhijin Fan4, Xiaotian Ji5, Bethany Mundy-Bosse2, Shunzong Yuan6, Tiffany Hughes2, Jianying Zhang7, Baljash Cheema3, Andrew T Camardo2, Yong Xia8, Lai-Chu Wu8, Li-Shu Wang9, Xiaoming He10, A Douglas Kinghorn3, Xiaohui Li11, Michael A Caligiuri12, Jianhua Yu12.
Abstract
Natural products are a major source for cancer drug development. NK cells are a critical component of innate immunity with the capacity to destroy cancer cells, cancer-initiating cells, and clear viral infections. However, few reports describe a natural product that stimulates NK cell IFN-γ production and unravel a mechanism of action. In this study, through screening, we found that a natural product, phyllanthusmin C (PL-C), alone enhanced IFN-γ production by human NK cells. PL-C also synergized with IL-12, even at the low cytokine concentration of 0.1 ng/ml, and stimulated IFN-γ production in both human CD56(bright) and CD56(dim) NK cell subsets. Mechanistically, TLR1 and/or TLR6 mediated PL-C's activation of the NF-κB p65 subunit that in turn bound to the proximal promoter of IFNG and subsequently resulted in increased IFN-γ production in NK cells. However, IL-12 and IL-15Rs and their related STAT signaling pathways were not responsible for the enhanced IFN-γ secretion by PL-C. PL-C induced little or no T cell IFN-γ production or NK cell cytotoxicity. Collectively, we identify a natural product with the capacity to selectively enhance human NK cell IFN-γ production. Given the role of IFN-γ in immune surveillance, additional studies to understand the role of this natural product in prevention of cancer or infection in select populations are warranted.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25122922 PMCID: PMC4162489 DOI: 10.4049/jimmunol.1302600
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422